Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Articles
Biotechnology / Pharmaceuticals
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Psychedelics
Regenerative Medicine
Disclosures
×
Gain Therapeutics Inc.
GANX:NASDAQ
Streetwise Company Fact Sheet
2025/2/22 13:24:07
(GANX:NASDAQ)
Analyst coverage
Maxim Group
—
Jason McCarthy
Chardan Capital Markets
—
Keay Nakae
Oppenheimer & Co.
—
Jay Olson
ROTH Capital Partners
—
Dr. Boobalan Pachaiyappan
H.C. Wainwright & Co.
—
Dr. Ram Selvaraju
BTIG Research
—
Dr. Thomas Shrader
Streetwise Reports Articles
12/30/2024 - View Article
12/26/2024 - View Article
12/10/2024 - View Article
Streetwise - Gain Therapeutics Inc. Ownership Overview*
Gain Therapeutics Inc.
(GANX:NASDAQ)
*
Share Structure as of 12/10/2024